Published on:
March 6, 2026
Fatty liver disease and gallstones are among the most common abdominal conditions encountered in clinical practice, yet many people carry them for years without knowing. An abdominal ultrasound is often the first — and most accessible — imaging tool used to detect both conditions, offering a safe, painless window into the health of your liver, gallbladder, and surrounding organs. Understanding what this scan can reveal is essential for catching problems early, before they progress to more serious complications.
Non-alcoholic fatty liver disease (NAFLD) is now the most prevalent chronic liver condition worldwide, affecting an estimated 25–30% of adults in Western countries. It occurs when excess fat accumulates in liver cells — typically more than 5% of the liver's weight — without a significant history of alcohol consumption. In its earliest stages, fatty liver is often completely asymptomatic, which is precisely what makes it so dangerous.
The condition exists on a spectrum. Simple steatosis (fat accumulation alone) is the mildest form and is generally considered reversible with lifestyle changes. However, in some individuals it progresses to non-alcoholic steatohepatitis (NASH), where inflammation and liver cell damage begin. Left unchecked, NASH can advance to fibrosis, cirrhosis, and even liver cancer. The key risk factors include obesity, type 2 diabetes, insulin resistance, high cholesterol, and metabolic syndrome.
What makes fatty liver particularly concerning is its silent nature. Most people feel perfectly well until significant damage has occurred. Routine blood tests may show mildly elevated liver enzymes, but these can also appear normal even when fat infiltration is present. This is where imaging — particularly ultrasound — becomes invaluable as a screening and diagnostic tool.
Gallstones are hardened deposits that form in the gallbladder, a small pear-shaped organ that stores bile produced by the liver. They can range in size from a grain of sand to a golf ball, and you may develop a single large stone, hundreds of tiny ones, or a combination of both. Gallstones affect approximately 10–15% of the adult population in the UK, with women, people over 40, and those who are overweight being at higher risk.
There are two main types of gallstones: cholesterol stones, which account for roughly 80% of cases and form when bile contains too much cholesterol, and pigment stones, which are smaller and darker, formed from excess bilirubin. Interestingly, fatty liver disease and gallstones share many of the same risk factors — obesity, rapid weight loss, high-fat diets, and metabolic disturbances — meaning they frequently coexist in the same patient.
Many people with gallstones experience no symptoms at all, a state known as "silent" gallstones. However, when a stone blocks a bile duct, it can cause sudden, intense pain in the upper right abdomen (biliary colic), nausea, vomiting, and sometimes fever. Complications such as cholecystitis (gallbladder inflammation), cholangitis (bile duct infection), and pancreatitis can be serious and may require emergency treatment. Early detection through imaging helps clinicians manage these risks proactively.
An abdominal ultrasound uses high-frequency sound waves to create real-time images of structures inside the abdomen. A trained sonographer applies a water-based gel to the skin and moves a small handheld device called a transducer across the area of interest. The transducer emits sound waves that bounce off internal organs and tissues, creating echoes that are converted into detailed images on a monitor.
Unlike CT scans or X-rays, ultrasound uses no ionising radiation, making it one of the safest imaging modalities available. It is also widely accessible, relatively inexpensive, and well-tolerated by patients. The examination typically takes between 15 and 30 minutes, and results are often available promptly. For these reasons, ultrasound is considered the first-line imaging investigation for evaluating the liver and gallbladder.
If you are experiencing abdominal discomfort, bloating, or digestive concerns, a general ultrasound can provide crucial diagnostic information. The scan can assess multiple organs in a single session, including the liver, gallbladder, kidneys, pancreas, spleen, and abdominal blood vessels, giving clinicians a comprehensive overview of your abdominal health.
On ultrasound, a healthy liver typically appears as a uniform, moderately echogenic (bright) structure. When fat infiltrates the liver cells, the organ's appearance changes in characteristic ways that an experienced sonographer can identify. The liver appears notably brighter than the adjacent kidney cortex — a finding often described as "increased echogenicity" — because fat reflects sound waves more strongly than normal liver tissue.
Fatty liver is generally graded on ultrasound into three stages. Grade 1 (mild) shows a slight increase in liver brightness with normal visualisation of the diaphragm and intrahepatic blood vessels. Grade 2 (moderate) demonstrates more pronounced brightness with some blurring of blood vessel walls. Grade 3 (severe) shows marked brightness with poor visualisation of the diaphragm and intrahepatic vessels, along with a significant loss of detail in the deeper portions of the liver.
Research confirms that ultrasound is both sensitive and specific for detecting moderate-to-severe fatty liver disease. A comprehensive meta-analysis found that ultrasonography allows reliable and accurate detection of moderate-to-severe fatty liver when compared to histological (biopsy) findings. Its advantages include safety, wide availability, low cost relative to CT or MRI, and minimal patient discomfort — making it an ideal screening tool for at-risk populations.
It is worth noting that ultrasound has limitations. It may be less reliable in detecting very mild fat accumulation (less than 20% fat content) and can be challenging in patients with very high body mass indices, where tissue depth reduces image quality. In such cases, more advanced techniques such as FibroScan or MRI-based fat quantification may be recommended for further evaluation.
Ultrasound is widely regarded as the gold standard for detecting gallstones, with a sensitivity exceeding 95% for stones within the gallbladder. On the scan, gallstones appear as bright, echogenic foci within the gallbladder that cast a characteristic acoustic shadow behind them. They are also typically mobile, shifting position when the patient changes posture — a feature that helps distinguish them from polyps, which remain fixed to the gallbladder wall.
Beyond simply identifying the presence of stones, an abdominal ultrasound can reveal a great deal about associated complications. Signs of acute cholecystitis include gallbladder wall thickening (greater than 3mm), pericholecystic fluid (fluid surrounding the gallbladder), and a positive sonographic Murphy's sign — tenderness when the ultrasound probe is pressed directly over the gallbladder. These findings help clinicians determine whether urgent intervention is needed.
Ultrasound can also assess the bile ducts for signs of obstruction. A dilated common bile duct (typically greater than 6mm in diameter, or 8–10mm in patients who have had their gallbladder removed) may suggest that a stone has migrated out of the gallbladder and is blocking the flow of bile. This is a critical finding, as bile duct obstruction can lead to jaundice, infection, and pancreatitis. As noted in the Merck Manual, ultrasound of the abdomen can help distinguish whether jaundice is caused by obstructed bile ducts or by malfunctioning liver cells — a distinction that fundamentally changes the treatment approach.
If your ultrasound reveals gallstones or related complications, your clinician may recommend further investigation such as blood tests to check liver function, or referral to a specialist for consideration of surgical management. For those experiencing gastro-intestinal symptoms alongside their findings, a broader digestive health assessment may be appropriate.
While anyone can develop fatty liver disease or gallstones, certain groups are at particularly elevated risk and may benefit from proactive screening. You should consider an abdominal ultrasound if you have any of the following risk factors or symptoms:
For individuals who are uncertain about their risk profile, routine health screenings can help identify early warning signs and determine whether imaging is warranted. Early detection of both fatty liver and gallstones can prevent serious complications and open the door to effective management strategies.
If your abdominal ultrasound reveals fatty liver disease, the management plan will depend on the severity of the findings and your overall health profile. For mild-to-moderate fatty liver, the cornerstone of treatment is lifestyle modification. This includes gradual, sustained weight loss (aiming for 7–10% of body weight), regular physical activity, a balanced diet rich in fruits, vegetables, and whole grains, and reduction or elimination of alcohol intake. There are currently no universally approved medications specifically for NAFLD, though several are in development and clinical trials.
Your doctor may recommend repeat ultrasound scans at regular intervals to monitor progression or improvement, alongside blood tests to track liver function. In cases where advanced fibrosis or cirrhosis is suspected, you may be referred for a FibroScan (transient elastography) or liver biopsy to assess the degree of scarring more precisely.
For gallstones, management depends on whether they are causing symptoms. Asymptomatic gallstones discovered incidentally on ultrasound generally do not require treatment, though patients are counselled on warning signs to watch for. Symptomatic gallstones — particularly those causing recurrent biliary colic, cholecystitis, or duct obstruction — are typically managed with laparoscopic cholecystectomy (keyhole surgery to remove the gallbladder), which remains one of the most commonly performed surgical procedures in the UK.
In some cases, both conditions may be present simultaneously, reflecting shared underlying metabolic disturbances. Addressing the root causes — such as obesity, poor diet, and sedentary behaviour — can have a positive impact on both the liver and the gallbladder, reducing future risk and improving overall health outcomes.
Proper preparation ensures the best possible image quality and the most accurate results. For an abdominal ultrasound focusing on the liver and gallbladder, you will typically be asked to fast for 6–8 hours before the appointment. Fasting allows the gallbladder to remain distended with bile, making stones and other abnormalities easier to visualise. A full gallbladder also provides better contrast against surrounding structures.
You should continue to take any prescribed medications with small sips of water unless specifically instructed otherwise by your clinician. Wear loose, comfortable clothing that allows easy access to your abdomen. The scan itself is entirely painless — you will feel gentle pressure from the transducer and the cool sensation of the gel, but there are no needles, injections, or discomfort involved.
After the scan, there are no restrictions. You can eat, drink, and return to your normal activities immediately. Your sonographer will review the images during and after the examination, and a detailed report will be provided to your referring clinician, who will discuss the findings and any recommended next steps with you.
Yes, abdominal ultrasound is effective at detecting moderate-to-severe fatty liver disease with high accuracy. However, very mild fat accumulation (less than approximately 20% of liver cells affected) can sometimes be missed on standard ultrasound. If clinical suspicion remains high despite a normal ultrasound, your doctor may recommend further investigation with FibroScan or MRI-based techniques for more precise fat quantification.
Ultrasound is the gold standard for gallstone detection, with a sensitivity of over 95% for stones located within the gallbladder. It is also excellent at identifying complications such as gallbladder wall thickening and bile duct dilatation. Stones within the common bile duct can be slightly harder to visualise on ultrasound due to overlying bowel gas, and additional investigations such as MRCP (magnetic resonance cholangiopancreatography) may be needed in those cases.
Abdominal ultrasound is extremely safe. It uses no ionising radiation and has no known harmful side effects, making it suitable for repeated use as often as clinically necessary. It is safe for all patient groups, including pregnant women and children. Your clinician will recommend an appropriate scanning interval based on your individual findings and risk factors.
Yes, and they frequently do. Both conditions share common risk factors including obesity, metabolic syndrome, insulin resistance, and high cholesterol. Studies have shown that individuals with NAFLD have a significantly higher prevalence of gallstones compared to the general population. An abdominal ultrasound can assess both the liver and gallbladder in a single examination, making it an efficient way to screen for both conditions simultaneously.
The most effective strategies include achieving and maintaining a healthy weight through gradual loss (avoiding crash diets, which can actually trigger gallstone formation), engaging in regular aerobic exercise for at least 150 minutes per week, following a Mediterranean-style diet rich in fruits, vegetables, whole grains, and healthy fats, limiting alcohol intake, and managing conditions such as diabetes and high cholesterol with appropriate medical support.
The information provided in this article is for educational purposes only and is based on NHS recommendations. It is not a substitute for professional medical advice. Always consult your doctor or a qualified healthcare provider for advice on medical conditions or treatments.
Our medical centre is at 36 Spital Square, E1 6DY, City of London.
